基因治疗的进步针对癌症中的突变KRAS基因治疗
Yuhang Wang1, Thuy Anh Bui1,2,3, Xinpu Yang1
1School of Biomedical Engineering, University of Technology Sydney, Ultimo, NSW, 2007, Australia.
Cancer metastasis reviews
|January 17, 2025
概括
新的KRAS疗法旨在对抗癌症的普遍应用. 本综述探讨基因疗法和纳米载体,以向KRAS突变,减少副作用,并改善各种癌症的疗效.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症遗传学 癌症遗传学
背景情况:
- 克拉斯基因突变是结直肠,胰腺和肺癌的关键驱动因素,促进细胞不受控制的生长.
- 目前的KRAS抑制剂对某些突变具有特异性,并可能导致显著的副作用.
- 需要普遍的治疗方法,针对更广泛的KRAS突变,降低毒性.
研究的目的:
- 审查基本的KRAS生物学及其在癌症发病过程中的作用.
- 检查当前的KRAS抑制剂及其局限性.
- 探索新兴的治疗策略,包括基因疗法和纳米载体输送系统,用于针对KRAS的癌症治疗.
主要方法:
- 对KRAS生物学,癌症突变和治疗策略的现有文献的审查.
- 分析当前的KRAS抑制剂及其临床应用.
- 探索基因治疗技术 (siRNA,miRNA,CRISPR) 和基于脂质的纳米载体用于基因传递.
主要成果:
- KRAS突变是关键的瘤驱动因素,但目前的治疗方法在特异性和副作用方面存在局限性.
- 基因治疗方法为更广泛地准KRAS突变提供了潜在的潜力.
- 基于脂质的纳米载体显示出对抗KRAS的有效基因疗法的承诺.
结论:
- 针对KRAS突变的新兴通用疗法对于改善癌症治疗结果至关重要.
- 基因治疗与纳米载体输送相结合,为未来的KRAS向癌症治疗提供了一个有希望的途径.
- 对这些新方法的进一步研究对于克服当前治疗挑战至关重要.
更多相关视频
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
17.8K
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
13.6K
相关概念视频
The Ras Gene
6.1K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.1K
Gene Therapy
25.2K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.2K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
In-vitro Mutagenesis
13.7K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
13.7K
What is Genetic Engineering?
73.5K
Overview
73.5K
